close

Multiple Myeloma

Multiple Myeloma

Treatment of Relapsed/Refractory Multiple Myeloma

Despite major and continuing treatment interventions, myeloma remains incurable for most patients, and relapse is an expected part of the disease course. At the National Comprehensive Cancer Network 12th Annual [ Read More ]

Multiple Myeloma

Treating Newly Diagnosed Multiple Myeloma in Transplant-Eligible Patients

  

Recent advances in the treatment of multiple myeloma have dramatically altered the trajectory of disease, as providers now have several efficacious agents in various drug classes at their disposal. At [ Read More ]

Multiple Myeloma

Darzalex Combined with Pomalidomide and Dexamethasone Approved for Relapsed/Refractory Multiple Myeloma

Daratumumab (Darzalex), in combination with pomalidomide (Pomalyst) and dexamethasone, for the treatment of patients with multiple myeloma who have received at least 2 previous therapies, including lenalidomide (Revlimid) and a [ Read More ]

Multiple Myeloma

This Year, March’s Myeloma Awareness Month Is Myeloma Action Month

Sophie Granger 

Although multiple myeloma is the second most common blood cancer, the majority of patients are unfamiliar with this type of cancer until they are diagnosed with the disease.1 In 2009, [ Read More ]